Literature DB >> 8891133

Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.

D Herbert1, C N Paramasivan, P Venkatesan, G Kubendiran, R Prabhakar, D A Mitchison.   

Abstract

The bactericidal actions of ofloxacin and sulbactam-ampicillin, alone and in combination with rifampin and isoniazid, on exponential-phase and stationary-phase cultures of a drug-susceptible isolate of Mycobacterium tuberculosis were studied in vitro. In exponential-phase cultures, all drugs were bactericidal, with the higher concentrations of ofloxacin (5 micrograms/ml) and sulbactam-ampicillin (15 micrograms of ampicillin per ml) being as bactericidal as 1 microgram of isoniazid per ml or 1 microgram of rifampin per ml. In two-drug combinations, both drugs increased the levels of activity of isoniazid and rifampin and were almost as bactericidal as isoniazid-rifampin; they also appeared to increase the level of activity of isoniazid-rifampin in three-drug combinations. In contrast, ofloxacin and sulbactam-ampicillin had little bactericidal activity against stationary-phase cultures and were less active than isoniazid or rifampin alone. Furthermore, in two-drug or three-drug combinations, they did not increase the level of activity of isoniazid, rifampin, or isoniazid-rifampin. These findings suggest that ofloxacin and sulbactam-ampicillin are likely to be most useful in the early stages of treatment and in preventing the emergence of resistance to other drugs but are unlikely to be effective as sterilizing drugs helping to kill persisting lesional bacilli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891133      PMCID: PMC163523     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells.

Authors:  G L HOBBY; T F LENERT
Journal:  Am Rev Tuberc       Date:  1957-12

2.  The action of antituberculosis drugs in short-course chemotherapy.

Authors:  D A Mitchison
Journal:  Tubercle       Date:  1985-09

3.  The early bactericidal activity of drugs in patients with pulmonary tuberculosis.

Authors:  A Jindani; V R Aber; E A Edwards; D A Mitchison
Journal:  Am Rev Respir Dis       Date:  1980-06

4.  Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.

Authors:  T B Sorg; M H Cynamon
Journal:  J Antimicrob Chemother       Date:  1987-01       Impact factor: 5.790

Review 5.  Pharmacokinetics of sulbactam/ampicillin in humans: a review.

Authors:  G Foulds
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

6.  Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.

Authors:  K Prabhakaran; E B Harris; B Randhawa; R C Hastings
Journal:  Microbios       Date:  1992

7.  Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.

Authors:  L B Heifets; P J Lindholm-Levy
Journal:  Tubercle       Date:  1987-12

8.  Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.

Authors:  J M Dickinson; D A Mitchison
Journal:  Am Rev Respir Dis       Date:  1981-04

9.  Antituberculosis activity of ofloxacin (DL 8280) on experimental tuberculosis in mice.

Authors:  M Tsukamura
Journal:  Am Rev Respir Dis       Date:  1985-10

10.  In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).

Authors:  M Tsukamura
Journal:  Am Rev Respir Dis       Date:  1985-03
View more
  27 in total

Review 1.  Drug-resistant tuberculosis: what do we do now?

Authors:  A Telenti; M Iseman
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

Review 3.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

4.  A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria.

Authors:  Makoto Niki; Mamiko Niki; Yoshitaka Tateishi; Yuriko Ozeki; Teruo Kirikae; Astrid Lewin; Yusuke Inoue; Makoto Matsumoto; John L Dahl; Hisashi Ogura; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

5.  Mechanism-independent method for predicting response to multidrug combinations in bacteria.

Authors:  Kevin Wood; Satoshi Nishida; Eduardo D Sontag; Philippe Cluzel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

6.  Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

Authors:  Sarah Schmidt Grant; Benjamin B Kaufmann; Nikhilesh S Chand; Nathan Haseley; Deborah T Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

7.  Inhibition of Bacillus anthracis spore outgrowth by nisin.

Authors:  Ian M Gut; Angela M Prouty; Jimmy D Ballard; Wilfred A van der Donk; Steven R Blanke
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

8.  Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.

Authors:  Ramesh Jayaram; Radha K Shandil; Sheshagiri Gaonkar; Parvinder Kaur; B L Suresh; B N Mahesh; R Jayashree; Vrinda Nandi; Sowmya Bharath; E Kantharaj; V Balasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  The DosR regulon of M. tuberculosis and antibacterial tolerance.

Authors:  I L Bartek; R Rutherford; V Gruppo; R A Morton; R P Morris; M R Klein; K C Visconti; G J Ryan; G K Schoolnik; A Lenaerts; M I Voskuil
Journal:  Tuberculosis (Edinb)       Date:  2009-07-03       Impact factor: 3.131

10.  Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.

Authors:  Carmela T M Mascio; Jeff D Alder; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.